RxCentric and Zestica Announce Creation of Trans-Atlantic Online Pharmaceutical Online Detailing Alliance.
NEW YORK and STOCKHOLM, Sweden--(BUSINESS WIRE)--Sept. 16, 2002
RxCentric Inc., a New York based leading provider of technology enabled sales and marketing solutions for the life sciences industry and Zestica KB, a leading provider of online sales and marketing solutions and consulting services for the life sciences industry in Europe, today announced the creation of a pioneering trans-Atlantic alliance that will expand their respective markets and enhance the online detailing services they offer to the industry.
Under the terms of the alliance, RxCentric and Zestica will collaborate on selected pharmaceutical and biotechnology online detailing projects in the U.S. and Europe through an integrated offering that leverages each company's core capabilities. The parties will also cross-market their products and services in the other's local markets and will share offices in the United States and Europe.
The joint offering will consist of RxCentric's comprehensive online pharmaceutical marketing products, including online detailing, CME, sampling and market research technologies and Zestica's strategic analytical tools, project management capabilities and established know-how in the areas of physician segmentation, marketing and program execution. The joint RxCentric and Zestica offering provides a comprehensive online solution enabling pharmaceutical firms to reach physicians and their patients with product specific information across two continents.
"RxCentric is pleased and excited to be partnering with Zestica, one of the only European companies with a proven record of success in designing, building and executing online detailing programs across multiple countries in Europe," said Richard Findlay, RxCentric's President and Chief Executive Officer. "This alliance will allow both companies to leverage their respective competitive advantages to win and execute online marketing business on a multi-national scale," Findlay continued.
Carl Ola Engelmarc, President and Chief Executive Officer of Zestica added, "We partnered with RxCentric because they helped pioneer online detailing in the United States and have proven their ability to execute projects based on their numerous program successes in the United States. The RxCentric and Zestica complementary offering will create significant added value for our existing and prospective clients in Europe wanting to develop and execute on-line sales and marketing programs."
RxCentric Inc. (www.rxcentric.com) is the pioneer of technology-enabled sales and marketing solutions for the life sciences industry providing customized and targeted online product marketing capability that extends the reach and frequency of existing offline marketing and sales activities. RxCentric's promotional and educational services include online detailing and sampling, online continuing medical education (CME) programs, as well as market research and sales representative support. RxCentric provides life sciences companies unprecedented access to a nationally representative population of prescribing physicians through its physician-only Doctors Net Access (DNA) medical information platform and through partnerships which give it access to nearly a half million physicians in the United States. RxCentric Inc. is a privately held company with locations in New York, Morristown NJ, and Philadelphia. Its clients include six of the ten largest pharmaceutical companies in the world, ranked by revenue.
Zestica (www.zestica.com) is a consulting company with market leading competence within business development and digital marketing communication. Zestica designs, packages and implements turn key digital solutions for the life sciences industry. As a result, life sciences companies can increase thier revenues; secure return on investment and streamline market communication. Zestica's core competence lies within areas such as business consulting, project management and information and system architecture, with services such as business analysis, business modelling and change management. Zestica is headquartered in Gothenburg and Stockholm Sweden, with affiliates in France, Spain, Italy, United Kingdom and Germany. Zestica is part of the A-Com-group (ticker A-Com, traded on the O-list of the Stockholm Exchange), whose business concept is to increase the customer's ability to generate revenue by combining expertise in market communications, the Internet and business development. A-Com consists of more than 50 part-owned companies with more than 650 employees, including associated companies.
CONTACT: RxCentric, New York Matthew Meyer, 212/629-7711, ext. 202 or Zestica, Stockholm Austin Wilson, +46 733 11 96 32 KEYWORD: NEW YORK INDUSTRY KEYWORD: MEDICAL MARKETING AGREEMENTS SOURCE: RxCentric
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 16, 2002|
|Previous Article:||knoa Announces Strategic Partnership with Firstwave Technologies.|
|Next Article:||The Benjamin School Tightens Campus Security With Converged 3Com Network.|